![]() |
市場調査レポート
商品コード
1629902
フィルターニードルの世界市場-2025~2033年Global Filter Needles Market - 2025-2033 |
||||||
カスタマイズ可能
適宜更新あり
|
フィルターニードルの世界市場-2025~2033年 |
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
|
フィルターニードルの世界市場は、2024年に18億米ドルに達し、2033年には36億米ドルに達し、予測期間2025年にはCAGR 7.7%で成長すると予測されています。
フィルターニードルは、バイアルやアンプルから注射器に薬剤を汚染なく安全に投与するためにヘルスケア環境で使用される医療機器です。これらのデバイスは通常、ガラス片、ゴム粒子、その他の汚染物質などの微粒子をブロックしながら液体を通過させるフィルターが組み込まれた中空の針で構成されています。針は、あらゆる粒子を捕捉する疎水性フィルターで設計されており、投与される薬剤に汚染物質がないことを保証します。これは、汚染に敏感な注射薬を扱う場合や、ガラスアンプルから薬剤を抽出する場合に特に重要です。
フィルターニードル市場は、慢性疾患の蔓延やヘルスケア環境における感染管理の重視の高まりなど、様々な要因によって大きな需要が生じています。例えば、米国疾病予防管理センター(CDC)によると、米国では推定1億2,900万人が米国保健社会福祉省が定義する少なくとも1つの主要な慢性疾患(心臓病、がん、糖尿病、肥満、高血圧など)を抱えています。針のデザインにおける技術的進歩も、安全性と効率を向上させることで需要を促進しています。特にヘルスケアインフラが拡大し、可処分所得が増加している地域では、医療処置においてこれらの要素が引き続き重要であるため、市場は今後も成長を続けると予想されます。
促進要因と抑制要因
外科手術と医療処置の増加
外科手術や医療処置の増加は、フィルターニードル市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられます。世界の手術件数の増加、特に新興市場における手術件数の増加が、投与中の汚染を防ぎ薬剤の安全性を確保するために、フィルターニードルのような無菌機器に対する需要の高まりにつながっています。例えば、Annals of Thoracic Surgery Short Reportsによると、心臓外科手術は毎年100万~150万件行われていると推定されています。
また、米国国立衛生研究所(NIH)の調査によると、88,273人の人口に対して年間4,642件の手術が行われています。白内障(22.8%)、帝王切開(3.8%)、骨折(3.27%)、ヘルニア(2.86%)が最も多い手術でした。44.2%が必須手術でした。NIHは、インド人口10万人あたり年間3,646件の手術が必要と推定しています。さらに、Annals of Thoracic Surgery Short Reportsによると、毎年100万から150万件の心臓外科手術が行われていると推定されています。
統合された安全機能や強化された素材など、フィルターニードルの設計における技術的改良は、より優れたフィルター機能を可能にし、汚染リスクを軽減します。このような進歩は、複雑な手技を行うヘルスケア提供者からの需要の増加に対応しています。
針による怪我のリスク
針に関連した傷害のリスクは、安全性に対する懸念とヘルスケア従事者の福利への影響により、フィルターニードル市場の成長を著しく阻害します。汚染を最小限に抑え、安全性を向上させるよう設計されたフィルターニードル技術の進歩にもかかわらず、偶発的な針刺し傷害のリスクは、特に病院、診療所、在宅医療環境のような管理の行き届かない環境では、依然として重大な問題です。
針に関連した傷害は依然として蔓延しており、ヘルスケア従事者や患者に影響を及ぼしています。これらの傷害は、汚染された注射針による感染など、深刻な結果につながる可能性があります。このようなリスクは、特に安全プロトコルの遵守を懸念する医療機関や医療提供者の間で、フィルターニードルの採用を妨げる要因となっています。例えば、米国疾病予防管理センター(CDC)の報告によると、針刺し・鋭利外傷(NSSI)は年間100万件以上発生しており、院内傷害の8%を占めています。
傷害の治療や安全対策の実施に伴う経済的負担は相当なものです。多くの病院や診療所は、傷害のリスクが低いと考えられている従来の針がまだ広く使用されているのに、より高価なフィルターニードルへの投資をためらっています。医療従事者のトレーニングや意識が十分でない地域では、フィルターニードルの誤用や誤装着が怪我につながる可能性があります。このため、これらの安全器具の普及率は鈍く、市場成長の妨げとなっています。
The global filter needles market reached US$ 1.8 billion in 2024 and is expected to reach US$ 3.6 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
Filter needles are medical devices used in healthcare settings to safely administer medications from vials or ampoules into syringes without contamination. These devices typically consist of a hollow needle with an integrated filter that allows fluids to pass through while blocking particulates such as glass shards, rubber particles, and other contaminants. The needle is designed with a hydrophobic filter to trap any particles, ensuring that the drugs administered are free from contaminants. This is particularly important when dealing with injectable drugs that are sensitive to contamination or when drawing drugs from glass ampoules.
The filter needles market is experiencing significant demand due to various factors, including the increasing prevalence of chronic diseases and the growing emphasis on infection control in healthcare settings. For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Technological advancements in needle design are also driving demand by improving safety and efficiency. The market is expected to continue growing as these factors remain critical in medical procedures, particularly in regions with expanding healthcare infrastructure and increasing disposable incomes.
Market Dynamics: Drivers & Restraints
Rising surgical and medical procedures
The rising surgical and medical procedures are significantly driving the growth of the filter needles market and are expected to drive the market over the forecast period. The rising number of surgeries worldwide, particularly in emerging markets, has led to higher demand for sterile equipment like filter needles to prevent contamination and ensure drug safety during administration. For instance, according to the Annals of Thoracic Surgery Short Reports, estimated that 1 to 1.5 million cardiac surgical procedures take place each year.
Additionally, according to the study conducted by the National Institute of Health(NIH), a total of 4,642 surgeries were performed per year for a population of 88,273. Cataracts (22.8%), Caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the commonest surgeries. 44.2% of surgeries belonged to the essential surgeries. NIH estimated that 3,646 surgeries would be required per 100,000 Indian population per year. Additionally, according to the Annals of Thoracic Surgery Short Reports, estimated that 1 to 1.5 million cardiac surgical procedures take place each year.
Technological improvements in filter needle design, such as integrated safety features and enhanced materials, allow better filtering capabilities and reduce contamination risks. These advancements cater to the increased demand from healthcare providers performing complex procedures.
Risk of needle-related injuries
The risk of needle-related injuries significantly hampers the growth of the filter needles market due to concerns over safety and the impact on healthcare workers' well-being. Despite advancements in filter needle technology designed to minimize contamination and improve safety, the risk of accidental needlestick injuries remains a critical issue, particularly in less controlled environments such as hospitals, clinics, and in-home healthcare settings.
Needle-related injuries are still prevalent, affecting healthcare workers and patients. These injuries can lead to serious consequences, including infections from contaminated needles. This risk discourages the adoption of filter needles, especially among institutions and healthcare providers who are concerned about compliance with safety protocols. For instance, the Centre for Disease Control and Prevention (CDC) reported that more than 1 million events of needle sticks and sharp injuries (NSSIs) have happened annually and represent 8% of in-hospital injuries.
The economic burden of treating injuries and implementing safety measures is considerable. Many hospitals and clinics are hesitant to invest in more expensive filter needles when traditional needles are still widely used, given the perceived lower risk of injury. In regions with inadequate training and awareness among healthcare professionals, the misuse or misapplication of filter needles can lead to injuries. This has resulted in a slow adoption rate of these safety devices, thereby hampering market growth.
The global filter needles market is segmented based on product type, material, application, end-user and region.
The blunt filter needles segment is expected to dominate the filter needles market share
Blunt filter needles are designed to prevent needlestick injuries and glove perforations risks by using a blunt, non-piercing tip. This makes them ideal for accessing medication vials and ampules without the risk of piercing through the vial's rubber stopper. This design reduces the risk of glass particles from ampules entering the medication during preparation, which is crucial for patient safety, especially when handling high-risk drugs and biologics. The use of blunt filter needles prevents injuries that could lead to serious health risks such as infections from accidental needle sticks.
For instance, according to the National Institute of Health (NIH), the use of blunt needles reduced the risk of glove perforations with a relative risk (RR) of 0.46 (95% confidence interval (CI) 0.38 to 0.54) compared to sharp needles. The use of blunt needles will thus prevent one glove perforation in every six operations.
Hospitals and clinics frequently use blunt filter needles for drug administration and sample collection due to their ability to handle medications without contamination risks. This widespread use has established the segment as a standard in medical procedures where sterility and safety are paramount. Home healthcare adoption of blunt filter needles also boosting as patients and caregivers prefer safer, user-friendly options for self-administration of medications.
North America is expected to hold a significant position in the filter needles market share
North America boasts a well-established healthcare infrastructure with widespread adoption of advanced medical technologies. The presence of a high number of hospitals, clinics, and outpatient settings that require sterile drug administration has increased the demand for filter needles.
For instance, according to the American Hospital Association, there are 6,120 hospitals in the United States, in that Community Hospitals are 5,129, Federal Government Hospitals are 207 and Nonfederal Psychiatric Hospitals are 659. The U.S., in particular, leads the market due to its high healthcare expenditure and the prevalence of chronic diseases that necessitate frequent medication administration.
In North America, there is a strong preference for safety-engineered needles, including blunt filter needles, due to the heightened awareness of healthcare-associated infections. These devices are widely used to minimize the risk of needlestick injuries, which are prevalent in healthcare settings. The use of blunt filter needles is particularly emphasized for drug administration, especially when dealing with biologics and high-risk medications.
The higher economic capabilities in North America enable healthcare facilities to invest in advanced and sometimes more expensive medical devices, including filter needles. This economic advantage, coupled with reimbursement policies that support the use of safer devices, has further propelled the dominance of the filter needles market in this region.
Asia-Pacific is growing at the fastest pace in the filter needles market
The APAC region is experiencing rapid economic growth, which is leading to increased investments in healthcare infrastructure. This economic growth enables governments and private entities to improve medical facilities and access to healthcare services, thereby driving demand for advanced medical devices like filter needles.
For instance, countries like China and India are investing heavily in healthcare infrastructure, which is crucial for the adoption of safety-engineered needles. These investments include upgrading hospitals, clinics, and other medical facilities, making it easier to implement devices like filter needles.
There is a growing awareness among healthcare providers and the general population in the APAC region about the importance of infection control and patient safety. This has led to an increased demand for safety-engineered needles, such as blunt filter needles, which are effective in reducing the risk of contamination and needlestick injuries. For instance, the adoption of filter needles in countries like India and Indonesia is accelerating due to improved healthcare policies and rising awareness about safe drug administration practices.
The major global players in the filter needles market include Becton, Dickinson, and Company, B. Braun Medical Inc., Cardinal Health, MYCO Medical Supplies, Inc., Terumo Corporation, ICU Medical, Inc., GBUK Group Ltd., Changzhou SUNTON Medical Technology Co., Ltd, Medline Industries, LP and among others.
The global filter needles market report delivers a detailed analysis with 67 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
LIST NOT EXHAUSTIVE